Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: Relevance to sporadic Alzheimer's disease?

Journal of Neural Transmission

Volumn 107, Issue 3, 2000, Pages 355-368

  Yun, S W ^a   Hoyer, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Brain glucose metabolism; Hexokinase; Lead; Pyruvate dehydrogenase

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; HEXOKINASE; LEAD; LEAD ACETATE; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX; PYRUVATE KINASE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN HOMOGENATE; BRAIN METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME INHIBITION; GLUCOSE METABOLISM; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RISK FACTOR;

EID: 0034022124     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050030     Document Type: Article

References (77)

1. Ali MS, Roche TE, Patel MS (1993) Identification of the essential cysteine residue in the active site of bovine pyruvate dehydrogenase. J Biol Chem 268: 22353-22356
2. Amatruda JM, Staton AJ, Kiesow LA (1977) Inhibition of carbon dioxide fixations by lead acetate in rat liver mitochondria. Biochem J 166: 75-79
3. Anderson CM, Zucker FH, Steitz TA (1979) Space-filling models of kinase clefts and conformation changes. Science 204: 375-380
4. Banks EC, Ferretti LE, Shucard DW (1997) Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology 18: 237-282
5. Basun H, Forssell LG, Wetterberg L, Winbald B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal ageing and Alzheimer's disease. J Neural Transm [P-D Sect]4: 231-258
6. Bennett WS, Steitz TA (1980) Structure of a complex between yeast hexokinase A and glucose. J Mol Biol 140: 211-230
7. Bergmeyer HU (1974) Methods in enzymatic analysis, vol 1. Verlag Chemie/Academic, New York London, pp 495-496
8. Bleecker ML, Lindgren KN, Ford D (1997) Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age. Neurology 48: 639-645
9. Burgess RW, Wilson JE (1991) Hexokinase levels in discrete regions of rat brain: evaluation by quantitative immunofluorescence using interactive laser cytometry and comparison with basal rates of glucose utilization. J Neurochem 57: 441-446
10. Burnstock G (1990) Purinergic mechanism. Ann NY Acad Sci 603: 1-17
11. Cho SW, Joshi JG (1988) Effect of long-term feeding of aluminum chloride on hexokinase and glucose-6-phosphate dehydrogenase in the brain. Toxicology 48: 61-69
12. Cohn J, Cox C, Cory-Slechta DA (1993) The effects of lead exposure on learning in a multiple repeated acquisition and performance schedule. Neurotoxicology 14: 329-346
13. Cory-Slechta DA (1990) Lead exposure during advanced age: alternations in kinetics and biochemical effects. Toxicol Appl Pharmacol 104: 67-78
14. Cory-Slechta DA, Weiss B, Cox C (1983) Delayed behavioral toxicity of lead with increasing exposure concentration. Toxicol Appl Pharmacol 71: 342-352
15. Cory-Slechta DA, Pokora MJ, Widzowski DV (1991) Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle. II. Delayed spatial alternation. Neurotoxicology 12: 761-776
16. Dietze EC, Schafer A, Omichinski JG, Nelson SD (1997) Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide. Chem Res Toxicol 10: 1097-1103
17. Drachman DA, Noffsinger D, Sahakian BJ, Kurdziel S, Fleming P (1980) Aging, memory and the cholinergic system: a study of dichotonic listening. Neubiol Aging 1: 39-43
18. Ehrlich YH, Davis TB, Bock E, Kornrcki E, Lenox RH (1986) Ecto-protein kinase activity on the external surface of neural cells. Nature 320: 67-70
19. Elnageh KM, Gaitonde MK (1988) Effect of deficiency of thiamine on brain pyruvate dehydrogenase: enzyme assay by three different methods. J Neurochem 51: 1482-1489
20. Engle MJ, Volpe JJ (1990) Glutamine synthetase activity of developing astrocytes is inhibited in vitro by very low concentrations of lead. Dev Brain Res 55: 283-287
21. Erecinska M, Silver IA (1989) ATP and brain function. J Cereb Blood Flow Metab 9: 2-19
22. Fernandez GO, Martinez RR, Fortoul TI, Palazuelos E (1997) High blood lead levels in ceramic folk art worker in Michoacan, Mexico. Arch Environ Health 52: 51-55
23. Frölich L, Ding A, Hoyer S (1995) Holeboard maze-learning deficits and brain monoaminergic neurotransmitter concentrations in rats after intracerebroventricular injection of 3-bromopyruvate. Pharmacol Biochem Behav 51: 917-922
24. Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Layfer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Beckmann H, Riederer P (1998) Insulin and insulin receptors in the brain in aging and in sporadic Alzheimer's disease. J Neural Transm 105: 423-438
25. Gething MJ, Sambrook J (1992) Protein folding in the cell. Nature 355: 33-45
26. Gibson GE, Blass JP (1976) Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycemia. J Neurochem 27: 37-42
27. Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondria enzyme in Alzheimer disease. J Neural Transm 105: 855-870
28. Gmerek DE, McCafferty MR, O'Neill KJ, Melmed BR, O'Neil JJ (1981) Effect of inorganic lead on rat brain mitochondrial respiration and energy production. J Neurochem 36: 1109-1113
29. Graves AB, van Duijin CM, Chandra V, Fratigliono L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A (1991) Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidem 20 [Suppl 2]: S58-S61
30. Haenninen H, Hernberg S, Mantere P, Vesanto R, Jalkanen M (1978) Psychological performance of subjects with low exposure to lead. J Occup Med 20: 683-689
31. Heiman AS, Tonner LE (1995) The acute effect of lead acetate on glucocorticoid regulation of tyrosine aminotransferase in hepatoma cells. Toxicology 100: 57-68
32. Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21: 63-74
33. Heroux M, Raghavendra-Rao VL, Lavoie J, Richardson JS, Butterworth RF (1996) Alteration of thiamine phosphorylation and thiamine-dependent enzymes in Alzheimer's disease. Metab Brain Dis 11: 81-88
34. Hershey CO, Hershey LA, Varnes A, Vibhakar SD, Lavin P, Strain WH (1983) Cerebrospinal fluid trace element content in dementia: clinical, radiological and pathologic correlations. Neurology 33: 1350-1353
35. Hirata M, Yoshida T, Miyajima K, Kosaka H, Tabuchi T (1995) Correlation between lead in plasma and other indicators of lead exposure among lead-exposed workers. Int Arch Occup Environ Health 68: 58-63
36. Hoyer S (1992) Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 16: 207-224
37. Hoyer S (1994) Age as risk factor for sporadic dementia of the Alzheimer type? Ann NY Acad Sci 719: 248-256
38. Hoyer S (1997) Models of Alzheimer's disease: cellular and molecular aspects. J Neural Transm 49 [Suppl]: 11-21
39. Hoyer S (1998) Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105: 415-422
40. Hoyer S, Nitsch R, Oesterreich K (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm [P-D Sect] 3: 1-14
41. Hunty J, Wilson JE (1990) Effect of ligand-induced conformational changes on the reactivity of specific sulfhydryl residues in rat brain hexokinase. Arch Biochem Biophys 283: 173-183
42. Hyland K, McBrien DCH (1979) The effect of lead nitrate on purified pig heart pyruvate dehydrogenase. Biochem Soc Trans 7: 1124-1126
43. Imahori K, Hoshi M, Ishiguro K, Sato K, Takahashi M, Shiurba R, Yamaguchi H, Takashima A, Uchida T (1998) Possible role of tau protein kinases in pathogenesis of Alzheimer's disease. Neurobiol Aging 19 [Suppl]: S93-98
44. Khailova LS, Aleksandrovich OV, Severin SE (1983) Study on the role of SH-groups in the activity of muscle pyruvate dehydrogenase. Biochem Int 7: 223-233
45. Lachant NA, Tomoda A, Tanaka R (1984) Inhibition of the pentose phosphate shunt by lead: a potential mechanism for hemolysis in lead poisoning. Blood 63: 518-524
46. Lai JCK, Baker A, Carson KC, Blass JP (1985) Different effects of monovalent, divalent and trivalent metal ions on rat brain hexokinase. Comp Biochem Physiol 80C: 291-294
47. Leong SF, Lai JCK, Lom L, Clark JB (1981) Energy-metabolising enzymes in brain regions of adult and aging rats. J Neurochem 37: 1548-1556
48. Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 112: 1199-1208
49. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275
50. López-Carrillo L, Torres-Sánchez L, Garrido F, Papaqui-Hernández J, Palazuelos-Rendón E, López-Cervantes M (1996) Prevalence and determinants of lead intoxication in mexican children of low socioeconomic status. Environ Health Perspect 104: 1208-1211
51. Lynch G, Baudry M (1984) The biochemistry of memory: a new and specific hypothesis. Science 224: 1057-1063
52. Mayer G, Nitsch R, Hoyer S (1990) Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res 532: 95-100
53. Miura T, Muraoka S, Ogiso T (1997) Inactivation of glyceraldehyde-3-phosphate dehydrogenase by ferrylmyoglobin. Chem Biol Interact 107: 173-183
54. Murakami K, Rose IA (1974) Inactivation and reactivation of hexokinase type II. Arch Biochem Biophys 165: 519-523
55. Murakami K, Feng G, Chen SG (1993) Inhibition of brain protein kinase C subtypes by lead. J Pharmacol Exp Ther 264: 757-761
56. Niklowitz WJ (1975) Neurofibrillary changes after acute experimental lead poisoning. Neurology 25: 927-934
57. Niklowitz WJ, Mandybur TI (1975) Neurofibrillary changes following childhood lead encephalopathy. J Neuropathol Exp Neurol 34: 445-455
58. Ouchi Y, Fukuyama H, Matsuzaki S, Ogawa M, Kimura J, Tsukada H, Kakiuchi T, Kosugi T, Nishiyama S (1996) Compartment analysis of cerebral glucose metabolism and in vitro glucose-metabolizing enzyme activities in the rat brain. Brain Res 706: 267-272
59. Pagliuca A, Mufti GJ, Baldwin D, Lesta AN, Wallis RM, Bellingham AJ (1990) Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak. J Clin Pathol 43: 277-281
60. Piert M, Koeppe RA, Giordani B, Berent S, Kuhl D (1995) Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med 37: 201-208
61. Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11:477-483
62. Prince M (1998) Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer's disease? Epidemiology 9: 618-621
63. Puri RN, Bhatnagar D, Roskoski R (1988) Inactivation of hexokinase by ophthalaldehyde: evidence for the presence of a cysteine and a lysin at or near the active site. Biochim Biophys Acta 957: 34-46
64. Rafter GW, Blair JB (1987) Reaction of liver pyruvate kinase with sulfhydryl reagents: effect on its activity. Biochim Biophys Acta 913: 195-199
65. Regunathan S, Sundaresan R (1984) Pyruvate metabolism in the brain of young rats intoxicated with organic and inorganic lead. J Neurochem 43: 1346-1351
66. Rice DC (1993) Lead-induced changes in learning: evidence for behavioral mechanisms from experimental animal studies. Neurotoxicology 14: 167-178
67. Rothenberg SJ, Williams FA, Delrahim S, Khan F, Kraft M, Lu M, Mamalo M, Sanchez M, Wooten D (1996) Blood lead levels in children in south central Los Angeles. Arch Environ Health 51: 383-388
68. Siebenlist K, Taketa F (1983) Inactivation of yeast hexokinase B triethyltin bromide and reactivation by dithiothreitol and glucose. Biochemistry 22: 4642-4646
69. Siesjö BK (1978) Brain energy metabolism. John Wiley & Sons, Chichester New York Brisbane Toronto, pp 117-120
70. Siesjö BK (1981) Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1: 155-185
71. Sterling GH, O'Neill K, McCafferty MR, O'Neill J (1982) Effect of chronic lead ingestion by rats on glucose metabolism and acetylcholine synthesis in cerebral cortex slices. J Neurochem 39: 592-596
72. Tomich JM, Colman RF (1985) Reaction of 5′-p-fluorosulfonylbenzoyl-1, N6-ethanoladenosine with histidine and cysteine residues in the active site of rabbit muscle pyruvate kinase. Biochim Biophys Acta 827: 344-357
73. Vallee BL, Ulmer DD (1972) Biochemical effect of mercury, cadmium and lead. Ann Rev Biochem 41: 91-115
74. Whitesell RR, Ward M, McCall AL, Granner DK, Ma JM (1995) Coupled glucose transport and metabolism in cultured neuronal cells: determination of the rate-limiting step. J Cereb Blood Flow Metab 15: 814-826
75. Wieraszko A, Ehrlich YH (1994) On the role of extracellular ATP in the induction of long-term potentiation in the hippocampus. J Neurochem 63: 1731-1738
76. Xu ZX, Fox L, Melethil S, Winberg L, Badr M (1990) Mechanism of aluminum-induced inhibition of hepatic glycolysis inactivation of phosphofructokinase. J Pharmacol Exp Ther 254: 301-305
77. Zeng C, Aleshin AE, Hardie JB, Harrison RW, Fromm HJ (1996) ATP-binding site of human brain hexokinase as studied by molecular modeling and site-directed mutagenesis. Biochemistry 35: 13157-13164